Drug Trial Radar · NCT01573052
Gabapentin vs Chlordiazepoxide for Ambulatory Alcohol Withdrawal
Last checked: Nov 20, 2026Latest source record: Aug 17, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
26
Actual
Start
Mar 2004
Primary completion
Aug 2010
Study completion Sep 2010
Sponsor
- Lead sponsor
- VA Salt Lake City Health Care SystemFederal agency
- Sponsor type
- Federal agency
- First posted
- Apr 6, 2012
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A randomized, double-blind controlled trial comparing treatment outcomes between chlordiazepoxide, or gabapentin to treat alcohol withdrawal syndrome in alcohol dependent veteran subjects. The objective of this trial is to compare the safety and effectiveness of these two medications. Intervention is a fixed dose taper of chlordiazepoxide, or gabapentin over 6 days. Subjects will be evaluated for 7-10 days to monitor alcohol abstinence, withdrawal severity scores, adverse events including ataxia, sedation, cognitive function and alcohol craving.
Conditions
- Alcohol Withdrawal
Interventions
ChlordiazepoxideDrug
25mg four times daily x 3 days then tapered over 3 days
GabapentinDrug
300mg four times daily x 3 days then tapered over 3 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Epworth Sleepiness Scale (ESS)Time frame: 1 week
- PENN Alcohol Craving ScaleTime frame: 1 week
Locations
1 site in 1 country. Site status is shown where the registry gives one.
George E Wahlen VA Medical Center
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.